Safety
Ipamorelin and CJC-1295: FDA status and what you can get
Ipamorelin and CJC-1295 have no FDA-approved product and no federal route for pharmacies. Status checked 16 Nov 2026, with the closest prescription option.
By Julian Caraulani · Updated November 16, 2026
Neither ipamorelin nor CJC-1295 is FDA-approved, and we found no federal route for a pharmacy to compound either one. FDA lists ipamorelin in Category 2, its list of substances with safety concerns, and CJC-1295 as a nomination that was withdrawn (FDA, page current as of 22 Apr 2026, read 16 Nov 2026). The closest peptide a licensed program prescribes is sermorelin, from $94 a month at Idun Rx.
Price checked Nov 19 · Cancel anytime · Medication included · No email needed
Compounded drugs are not FDA-approved. Neither peptide is among the six covered by the interim HHS policy of 28 Oct 2026 (Federal Register 2026-22192), and that policy can be withdrawn. No new FDA or HHS action on either was found on 16 Nov 2026. See our peptide legal status tracker.
What each one is
Both peptides are lab-made signals that lead the pituitary gland, a small gland at the base of the brain, to release growth hormone. They start from different places.
Ipamorelin is a five-amino-acid peptide that copies ghrelin, a hunger hormone. The paper that introduced it said it "stimulates GH release via a GHRP-like receptor" (Raun 1998, PubMed 9849822). CJC-1295 is a modified copy of growth hormone releasing hormone, the brain's own signal. It is built to last longer in the body than the natural signal. Neither has an approved drug label, so there is no official list of uses.
Status of each, in plain words
| Ipamorelin | CJC-1295 | |
|---|---|---|
| FDA-approved product | None | None |
| Among the six HHS interim-policy peptides | No | No |
| FDA's compounding list | Category 2 for outsourcing facilities since 29 Sep 2023; request for local pharmacies withdrawn | Nomination withdrawn |
| Tracked telehealth programs that price it | None | None |
A 503A pharmacy is a state-licensed local pharmacy that makes a drug for one patient. A 503B outsourcing facility makes larger batches. For 503A pharmacies, FDA's page lists both peptides under substances "nominated but withdrawn", which means no one is asking FDA to approve them for that route. A seller offering either one works outside the federal routes we found.
Price checked Nov 19 · Cancel anytime · Medication included · No email needed
What FDA says about safety
On ipamorelin, FDA says compounded versions may carry a risk of an immune reaction, and it points to "serious adverse events including death when ipamorelin was administered intravenously" in a published study (FDA, read 16 Nov 2026). FDA says it has no safety information for some other injection routes, which is not the same as saying they are safe.
On CJC-1295, the same page lists "increased heart rate and systemic vasodilatory reaction", meaning a widening of blood vessels, among serious adverse events FDA has identified. It adds that available clinical data are limited. We read both entries on 16 Nov 2026.
What human evidence exists
Ipamorelin's record in people is thin. One study in healthy men measured how the body absorbs and clears it and how much growth hormone rose (Gobburu 1999, PubMed 10496658). The one trial of results we found tested it in 117 adults after bowel surgery. It was "well tolerated" but did no better than placebo on the main goals (Beck 2014, PubMed 25331030). Neither study tested anti-aging or body composition.
For CJC-1295 we found no approved label and no trial that shows a benefit for healthy adults. Claims you see online that these peptides build muscle or reverse aging are not backed by published trials in healthy people.
Why people mention them together
Online, ipamorelin and CJC-1295 are often sold as one blend. We do not cover blends or how to use them. Neither peptide has an approved product, and a blend of the two has no federal compounding route either. Our rules also keep us from publishing doses, schedules or mixing steps for any peptide.
What you can do instead
If your goal is a growth hormone peptide through a licensed clinician, sermorelin is the one with a compounding route today. Programs that print a price start at $94 a month at Idun Rx (12-month plan), and each program's page says compounded drugs are not FDA-approved. Compare them on the sermorelin price page, and read sermorelin vs ipamorelin for the side-by-side. Your prescriber decides whether any option fits you.
For an approved growth hormone releasing drug with a single labelled use, see tesamorelin vs ipamorelin. To price every program we track, see what peptides cost. Sites that sell ipamorelin or CJC-1295 are usually labelled "for research use", which we do not cover; see research vs prescription peptides.
FAQ
Ipamorelin and CJC-1295: are they FDA-approved?
No. Neither has an FDA-approved product. FDA lists ipamorelin in Category 2 for outsourcing facilities and shows both peptides as nominations that were withdrawn for local pharmacies. Neither is in the HHS interim policy. Status can change, so check the date at the top of this page.
Is ipamorelin legal?
Ipamorelin is not approved, FDA lists it in Category 2, and it is not in the HHS policy. We found no federal route for a pharmacy to compound it. A seller offering it works outside the frameworks we track.
Can you get ipamorelin or CJC-1295 with a prescription?
We track no licensed telehealth program that prices either one. Programs that print a price prescribe other peptides, such as sermorelin. Ask a clinician about options that have a compounding route or an approved label.
Ipamorelin vs CJC-1295: what is the difference?
Ipamorelin copies ghrelin, a hunger hormone, and CJC-1295 copies the brain's growth hormone releasing signal. Both lead to a release of growth hormone. Neither has an approved product, and we found no head-to-head human trial.
What is the cost of ipamorelin?
We publish no ipamorelin price because no licensed program we track sells it. The cheapest sermorelin program, the closest option with a route, is on our sermorelin price page.
Is CJC-1295 safe?
FDA lists "increased heart rate and systemic vasodilatory reaction" among serious adverse events and says clinical data are limited. There is no approved label with a full safety review. Talk to a prescriber before considering it.
Bottom line
Neither peptide has an approved product or a federal compounding route today. To price the options that do have one, use the cost page or see our best peptide programs.
Check this page with an AI assistant:ChatGPTPerplexityClaude
Not affiliated with OpenAI, Perplexity or Anthropic.